In humans, repeated exposure to psychostimulants such as amphetamine or cocaine increases sensitivity to these drugs which may precipitate psychosis (Ellison 1994) . Behavioral sensitization to psychostimulants can also be elicited in experimental animals, and is associated with increased dopamine neurotransmission in the nucleus accumbens (Kalivas and Stewart 1991) . Thus, psychostimulant sensitization in rodents is widely used to model neuroadaptive changes underlying schizophrenia (Kalivas and Stewart 1991; Robinson and Becker 1986) .
Disruption of prepulse inhibition (PPI) is believed to reflect sensorimotor gating deficits present in patients with schizophrenia (Swerdlow et al. 1994) . PPI is the attenuation of startle response to a high intensity stimulus (e.g., auditory) following exposure to a low intensity prestimulus. Psychostimulants elicit PPI deficits in experimental animals presumably via indirect dopamine receptor stimulation in the nucleus accumbens, providing another experimental model of schizophrenia symptoms (Swerdlow et al. 1992 (Swerdlow et al. , 1994 .
As models of schizophrenia, these paradigms might be expected to exhibit a certain degree of consistency reflected by enhanced PPI disruption in behaviorally sensitized animals. However, attempts to determine whether amphetamine-or apomorphine-induced PPI deficits are augmented by repeated treatment have yielded conflicting results (Druhan et al. 1998; Mansbach et al. 1988; Taylor et al. 1995; Zhang et al. 1998) . Thus, the present study was conducted to determine whether these models could be differentiated when cocaine was used as the sensitizing agent.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats (National Cancer Institute, Frederick, MD) weighing 200-250 g were housed in groups of 2-3 on a 12:12 hr light:dark cycle with food and water available ad libitum. All procedures were reviewed and approved by the Tufts-New England Medical Center Animal Care and Use Committee, and were conducted in accordance with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the National Institutes of Health.
Behavioral Assessment
The procedure for monitoring stereotypy has been described in detail elsewhere (Byrnes et al. 2000) . Briefly, animals were placed individually into testing chambers (45 ϫ 24 ϫ 15 cm) and the percent time spent engaging in stereotypic movement was quantified using the PolyTrack Video Tracking System (San Diego Instruments, San Diego, CA). The tracking parameters used accurately reflect small movements including normal grooming and psychostimulant-induced stereotypy (Robinson and Becker 1986) .
Assessment of startle response and PPI was accomplished using an SR-Pilot startle chamber (San Diego Instruments). Stimulus parameters included 65 dB broad band background noise and two trial types: a basic startle pulse stimulus of 40 ms, 115 dB broad band noise, and a prepulse sequence consisting of a 40 ms, 85 dB stimulus preceding the startle stimulus by 100 ms. Peak startle amplitude was determined in arbitrary response units. Each animal received 63 stimuli in pseudorandom order with 15 s interstimulus intervals. Percent of PPI expressed by individual animals within each test session was calculated as follows:
Experimental Design
Effect of Repeated Cocaine on Stereotypic Behavior. Animals received either cocaine (30 mg/kg, i.p.; NIDA Drug Supply Program) or vehicle (0.9% saline, 1 ml/kg, i.p.) once daily for a total of seven days (Days 1-7). Each animal, then, received the same treatment following a seven day withdrawal period (Day 14). The magnitude of stereotypic activity was assessed for 50 min following treatment on Days 1 and 14. This paradigm significantly augments motor behavior in the absence of any apparent seizure activity (Byrnes et al. 1999; Pierce et al. 1996) .
Effect of Repeated Cocaine on PPI and Startle. Two days prior to treatment, experimental groups were matched to ensure uniform pretreatment startle responding. All treatment procedures were identical to those described for Experiment 1, except that animals were challenged on Day 14 with either cocaine (30 mg/kg, i.p.) or saline followed 5 min later by PPI and startle testing. 
RESULTS AND DISCUSSION
Cocaine challenge significantly increased stereotypic activity following repeated treatment ( Figure 1) ; group mean percent activity was 55.3 Ϯ 5.0% after cocaine challenge on Day 1 and 73.3 Ϯ 7.1% on Day 14. In addition, the incidence of abnormal focused behaviors (e.g., intense sniffing, repetitive head bobbing) was greater after cocaine treatment on Day 14 than on Day 1. Repeated saline treatment produced equivalent amounts of small movements and grooming at both test times; group mean percent activity was 63.6 Ϯ 4.4% on Day 1 and 71.3 Ϯ 7.1% on Day 14.
Exposure to a sensitizing regimen of cocaine also altered the drug's ability to disrupt PPI (Figure 2 ). Cocaine challenge on Day 14 in animals treated repeatedly with saline disrupted PPI with a magnitude similar to that reported elsewhere (Martinez et al. 1999) . However, repeated cocaine treatment produced a complete blockade of this effect without altering PPI response to saline challenge. This is consistent with the effect of repeated amphetamine treatment which produces locomotor sensitization but not augmentation of PPI deficits (Druhan et al. 1998) . Repeated cocaine treatment also produced a nonsignificant rise (61%) in startle response to Pulse stimuli following challenge with either cocaine or saline (Table 1) , an effect which might reflect withdrawal-induced anxiety (Sarnyai 1998; Mutschler and Miczek 1998) . Since this effect was characterized by proportional changes in Pulse-and Prepulse-induced responses, it is unlikely that increased startle amplitude biased the magnitude of PPI observed.
The opposing effects of repeated cocaine treatment on motor behavior and PPI might be explained by differential adaptation of dopamine receptors. Behavioral sensitization to cocaine is associated with enhanced D 1 -like receptor sensitivity in the nucleus accumbens (Henry and White 1991). Conversely, repeated treatment with selective D 2 -like receptor agonists appears to downregulate D 2 -like receptor density (Subramaniam et al. 1992) , reduce the level of D 2 -like receptor-coupled G i protein (Nestler et al. 1990) , and decrease the physiological response to D 2 -like agonists (Henry et al. 1998) in the nucleus accumbens. Thus, cocaine-induced D 1 -like receptor enhancement with concurrent desensitization of D 2 -like receptors could account for the simultaneous sensitization of motor activity and tolerance to PPI disruption. Accordingly, the present finding is of particular interest with regard to the therapeutic potential of subchronic treatment with selective dopamine receptor agonists in schizophrenia.
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